Obesity is a chronic health issue that requires long-term management and is associated with severe health complications, including heart disease, diabetes, sleep apnea, asthma, hormonal concerns for women such as PCOS, arthritis, and certain types of cancer. Losing five to ten percent of body weight can bring impactful health benefits, such as:
-
Reduced risk of heart disease
-
Improved energy
-
Improved blood pressure, blood sugar, and cholesterol levels
On June 4, 2021, the U.S. Food and Drug Administration (FDA) approved Wegovy® for adults who suffer from obesity or are overweight. This is the first drug for chronic weight management that has been approved since 2014.
Combined with a reduced-calorie meal plan and increased physical activity, Wegovy® can be highly effective in helping patients lose weight.
Dedicated to providing individualized solutions, we recognize Wegovy® as an outstanding choice; however, we aim to highlight alternatives for patients seeking the most suitable treatment for weight management. Our physicians may recommend or prescribe other GLP-1 options depending on availability and individual preferences. Explore these choices:
-
Semaglutide: Due to shortages, compounded semaglutide may be prescribed as an alternative to branded Wegovy® as long as it remains on the FDA drug shortages list. Although compounded semaglutide is not FDA-approved, our pharmacy provider complies with pertinent federal and state laws and FDA regulations.*
-
Zepbound® (tirzepatide): A breakthrough in weight management, this dual-action GLP-1 and GIP receptor agonist not only aids in regulating blood sugar levels, but also presents a promising avenue for effective weight loss.
Other medications our doctors may prescribe for weight loss include:
*As of 1/4/2024, availability for compounded semaglutide is currently limited to residents in the following states: AZ, CA, CO, DC, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MT, ND, NE, NH, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, UT, WA, WY. Although compounded semaglutide is not FDA-approved, our pharmacy provider complies with all federal and state laws and FDA regulations. Doses of Wegovy® that are in shortage will be available as compounded semaglutide only until the shortage has ended.
.svg){kind=logo}
